Liquidia Stock
Liquidia Corporation
Company data
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- Country
- United States
- CEO
- Roger A. Jeffs
- Employees
- 216
- Market cap
- $3.1 B
- IPO
- 26/07/2018
Liquidia Corporation operates as a biopharmaceutical enterprise within the healthcare sector, with its headquarters located in Morrisville, US. The company focuses on the development, production, and market introduction of various treatments intended to fulfill critical patient requirements throughout the United…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
Liquidia stock: price history
1D
-1.2%
1W
+25.5%
1M
-49.8%
6M
-13.0%
YTD
-0.4%
1Y
+48.2%
2Y
+195.4%
5Y
+973.4%
10Y
–
Next earnings date
Next earnings date
02/11/2026 (in 16 days)
Volatility around earnings
~12% weaker price swings than usual
Liquidia stock scores
- Valuation
Visible after free registration
- Trend
Visible after free registration
- Quality
Visible after free registration
- Dividend
Visible after free registration
- Growth
Visible after free registration
- Insider
Visible after free registration
- Earnings
Visible after free registration
- Revisions
Visible after free registration
- Sentiment
Visible after free registration
- Short Pressure
Visible after free registration
Register for free
Unlock all 11 scores
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 10/09/2026.
Ask the agents about Liquidia
Analyst assessment of Liquidia
PRICE TARGET LOW
US$33.00
CONSENSUS
US$72.36
MEDIAN
US$65.00
PRICE TARGET HIGH
US$130.00
0
STRONG BUY
4
BUY
4
HOLD
1
SELL
0
STRONG SELL
9
TOTAL · Buy
As of: 02/10/2026
Liquidia stock metrics
P/E
21.89
P/B
15.65
EV/EBITDA
16.42
RETURN ON EQUITY
38.3%
NET MARGIN
43.5%
DEBT/EQUITY
0.66
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
72.9%
FLOAT SHARES
65,232,290
AVG. DAILY VOLUME (30D)
4,929,243
Insider transactions (SEC)
JEFFS ROGER
JEFFS ROGER
JEFFS ROGER
Boyle Dana
Boyle Dana
Attention
1 mention today in US forums, about the same as yesterdayPrice since yesterday: -1.2%
Forums (Reddit)
Institutional holders
Comparable stocks
Frequently asked questions about Liquidia stock
What does Liquidia do?
Liquidia Corporation is a company in the Healthcare sector, Medical - Pharmaceuticals industry, headquartered in United States.
The CEO is Roger A. Jeffs, the company employs around 216 people.
The IPO was on 26/07/2018; the stock trades on NASDAQ under the ticker LQDA.
What do analysts say about Liquidia stock?
9 analysts rate the stock, the consensus is Buy (as of 02/10/2026).
The average price target is US$72.36, ranging from US$33.00 to US$130.00, with a median of US$65.00.
This is an external assessment, not a statement by Market Jury.
When does Liquidia report next?
The next earnings date is 02/11/2026.
Around past earnings, price swings were roughly -12% stronger than usual.
Does Liquidia pay a dividend?
No, Liquidia currently does not pay a dividend.
Which stocks are comparable to Liquidia?
Comparable stocks include Corcept Therapeutics, Latigo Biotherapeutics, Helus Pharma, Eli Lilly and Company, Johnson & Johnson, AbbVie, Merck & and UnitedHealth Group.
How can I get Liquidia stock analyzed?
Clicking "Analyze stock" lets five strategies assess Liquidia against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.